Measurement of hemoglobin A1c (HbA1c) is considered the gold standard for monitoring chronic glycemia of diabetes patients. Hemoglobin A1c indicates an average of blood glucose levels over the past 3 months. Its close association with the risk for the development of long-term complications is well established. However, HbA1c does not inform patients about blood glucose values on a daily basis; therefore, frequent measurements of blood glucose levels are necessary for the day-to-day management of diabetes. Clinicians understand what HbA1c means and how it relates to glucose, but this is not the case with patients. Therefore, the translation of the HbA1c results into something more familiar to patients seemed a necessity.
The scope of this article is to review the literature to search for enough scientific evidence to support the idea of a close relationship between HbA1c and mean blood glucose (MBG), and to justify the translation of HbA1c into something that reflects the MBG.
Most studies confirm a close relationship between HbA1c and MBG, although different studies result in different linear equations. Factors affecting this relationship may limit the usefulness and applicability of a unique mathematical equation to all diabetes populations.
NathanDM. Long-term complications of diabetes mellitus. N Engl J Med.1993;328 (23): 1676–85.
2.
KilpatrickES. Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J Clin Pathol.2008;61 (9): 977–82.
3.
PaulingLItanoHASingerSJWellsIC. Sickle cell anemia: A molecular disease. Science.1949;110 (2865): 543–8.
4.
KunkelHGWalleniusG. New hemoglobin in normal adult blood. Science.1955;122 (3163): 288.
5.
AllenDWSchroederWABalogJ. Observations on the chromatographic heterogeneity of normal adult and fetal human hemoglobin: A study of the effects of crystallization and chromatography on the heterogeneity and isoleucine content. J Am Chem Soc.1958;80 (7): 1628–34.
6.
RahbarSBlumenfeldORanneyHM. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun.1969;36 (5): 838–43.
7.
RahbarS. An abnormal hemoglobin in red cells of diabetics. Clin Chim Acta.1968;22 (2): 296–8.
8.
SchnekASchroederW. The relation between the minor components of whole normal human adult hemoglobin as isolated by chromatography and starch block electrophoresis. J Am Chem Soc.1961;83: 1472–8.
9.
BrownleeM. Negative consequences of glycation. Metabolism.2000;49 (2Suppl 1): 9–13.
10.
McCanceDRDyerDGDunnJABailieKEThorpeSRBaynesJWLyonsTJ. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest.1993;91 (6): 2470–8.
11.
ThorpeSRBaynesJW. Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging.1996;9 (2): 69–77.
12.
VlassaraHBrownleeMCeramiA. Nonenzymatic glycosylation: Role in the pathogenesis of diabetic complications. Clin Chem.1986;32 (10 Suppl): B37–41.
13.
BrownleeMCeramiAVlassaraH. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab Rev.1988;4 (5): 437–51.
14.
VlassaraHFuhHMakitaZKrungkraiSCeramiABucalaR. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: A model for diabetic and aging complications. Proc Natl Acad Sci USA.1992;89 (24): 12043–7.
15.
McDonaldMJShapiroRBleichmanMSolwayJBunnHF. Glycosylated minor components of human adult hemoglobin. Purification, identification, and partial structural analysis. J Biol Chem.1978;253 (7): 2327–32.
16.
HoelzelWMiedemaK. Development of a reference system for the international standardization of HbA1c/glycohemoglobin determinations. J Int Fed Clin Chem.1996;9 (2): 62–7.
17.
FiedlerHZawtaB. Fundamentals in laboratory medicine: Diabetes mellitus and metabolic syndrome. Mannheim: Roche Diagnostics; 2004.
18.
ShapiroRMcManusMJZalutCBunnHF. Sites of nonenzymatic glycosylation of human hemoglobin A. J Biol Chem.1980;255 (7): 3120–7.
19.
GoldsteinDELittleRRLorenzRAMaloneJINathanDPetersonCMSacksDB. Tests of glycemia in diabetes. Diabetes Care.2004;27 (7): 1761–73.
20.
BunnHF. Nonenzymatic glycosylation of protein: Relevance to diabetes. Am J Med.1981;70 (2): 325–30.
SvendsenPALauritzenTSøegaardUNerupJ. Glycosylated haemoglobin and steady-state mean blood glucose concentration in Type 1 (insulin-dependent) diabetes. Diabetologia.1982;23 (5): 403–5.
23.
CefaluWTWangZQBell-FarrowAKigerFDIzlarC. Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia. Clin Chem.1994;40 (7 Pt 1): 1317–21.
24.
KilpatrickES. Glycated haemoglobin in the year 2000. J Clin Pathol.2000;53 (5): 335–9.
25.
TaharaYShimaK. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care.1995;18 (4): 440–7.
26.
KilpatrickES. Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J Clin Pathol.2008;61 (9): 977–82.
27.
BloomgardenZT. A1c: Recommendations, debates, and questions. Diabetes Care.2009;32 (12): e141–7.
28.
AleyassineH. Glycosylation of hemoglobin S and hemoglobin C. Clin Chem.1980;26 (3): 526–7.
29.
RobertsWLFrankELMoultonLPapadeaCNoffsingerJKOuCN. Effects of nine hemoglobin variants on five glycohemoglobin methods. Clin Chem.2000;46 (4): 569–72.
30.
BryLChenPCSacksDB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem.2001;47 (2): 153–63.
31.
TsaiLYTsaiSMLinMNLiuSF. Effect of hemoglobin variants (Hb J, Hb G, and Hb E) on HbA1c values as measured by cation-exchange HPLC (Diamat). Clin Chem.2001;47 (4): 756–8.
32.
RobertsWLDeBKBrownDHanburyCMHoyerJDJohnWGLambertTLLundellRBRohlfingCLittleRR. Effects of hemoglobin C and S traits on eight glycohemoglobin methods. Clin Chem.2002;48 (2): 383–5.
33.
BisséESchauberCZornNEptingTEigelAVan DorsselaerAWielandHKisterJKigerL. Hemoglobin Görwihl [alpha2beta(2)5(A2)Pro–> Ala], an electrophoretically silent variant with impaired glycation. Clin Chem.2003;49 (1): 137–43.
34.
RobertsWLSafar-PourSDeBKRohlfingCLWeykampCWLittleRR. Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods. Clin Chem.2005;51 (4): 776–8.
35.
LeeSTWeykampCWLeeYWKimJWKiCS. Effects of 7 hemoglobin variants on the measurement of glycohemoglobin by 14 analytical methods. Clin Chem.2007;53 (12): 2202–5.
36.
LittleRRRohlfingCLHansonSConnollySHigginsTWeykampCWD'CostaMLuzziVOwenWERobertsWL. Effects of hemoglobin (Hb) E and HbD traits on measurements of glycated Hb (HbA1c) by 23 methods. Clin Chem.2008;54 (8): 1277–82.
37.
MongiaSKLittleRRRohlfingCLHansonSRobertsRFOwenWED'CostaMAReyesCALuzziVIRobertsWL. Effects of hemoglobin C and S traits on the results of 14 commercial glycated hemoglobin assays. Am J Clin Pathol.2008;130 (1): 136–40.
BrooksAPMetcalfeJDayJLEdwardsMS. Iron deficiency and glycosylated haemoglobin A. Lancet.1980;2 (8186): 141.
40.
DavisREMcCannVJNicolDJ. Influence of iron-deficiency anaemia on the glycosylated haemoglobin level in a patient with diabetes mellitus. Med J Aust.1983;1 (1): 40–1.
41.
TarimOKüçükerdoğanAGünayUEralpOErcanI. Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus. Pediatr Int.1999;41 (4): 357–62.
42.
El-AgouzaIShahlaA AbuSirdahM. The effect of iron deficiency anaemia on the levels of haemoglobin subtypes: Possible consequences for clinical diagnosis. Clin Lab Haematol.2002;24 (5): 285–9.
43.
CobanEOzdoganMTimuragaogluA. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol.2004;112 (3): 126–8.
44.
KogaMMoritaSSaitoHMukaiMKasayamaS. Association of erythrocyte indices with glycated haemoglobin in pre-menopausal women. Diabet Med.2007;24 (8): 843–7.
45.
KilpatrickESRigbyASAtkinSL. The relationship between mean glucose and HbA1c in premenopausal women compared with males in the Diabetes Control and Complications Trial. Diabet Med.2008;25 (1): 112–3.
46.
LumG. Artefactually low hemoglobin A1c in a patient with hemolytic anemia. Lab Med.2010;41 (5): 267–70.
47.
HerranzLGrandeCJanezMPallardoF. Red blood cell auto-antibodies with a shortened erythrocyte life span as a cause of lack of relation between glycosylated hemoglobin and mean blood glucose levels in a woman with type 1 diabetes. Diabetes Care.1999;22 (12): 2085–6.
48.
LiewCFCheahJS. Hereditary spherocytosis, a pitfall in the assessment of glycaemic control. Singapore Med J.2003;44 (2): 94–7.
49.
KutterDThomaJ. Hereditary spherocytosis and other hemolytic anomalies distort diabetic control by glycated hemoglobin. Clin Lab.2006;52 (9–10): 477–81.
50.
JiaoYOkumiyaTSaibaraTParkKSasakiM. Abnormally decreased HbA1c can be assessed with erythrocyte creatine in patients with a shortened erythrocyte age. Diabetes Care.1998;21 (10): 1732–5.
51.
WeykampCWPendersTJSiebelderCWMuskietFAvan der SlikW. Interference of carbamylated and acetylated hemoglobins in assays of glycohemoglobin by HPLC, electrophoresis, affinity chromatography, and enzyme immunoassay. Clin Chem.1993;39 (1): 138–42.
52.
VirtueMAFurneJKNuttallFQLevittMD. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care.2004;27 (4): 931–5.
53.
MoscaAPaleariRDalfràMGDi CianniGCuccuruIPellegriniGMalloggiLBonomoMGranataSCeriottiFCastiglioniMTSonginiMToccoGMasinMPlebaniMLapollaA. Reference intervals for hemoglobin a1c in pregnant women: Data from an Italian multicenter study. Clin Chem.2006;52 (6): 1138–43.
NielsenLREkbomPDammPGlümerCFrandsenMMJensenDMMathiesenER. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care.2004;27 (5): 1200–1.
56.
HashimotoKNoguchiSMorimotoYHamadaSWasadaKImaiSMurataYKasayamaSKogaM. A1c but not serum glycated albumin is elevated in late pregnancy owing to iron deficiency. Diabetes Care.2008;31 (10): 1945–8.
57.
HartlandAJSmithJMClarkPMWebberJChowdhuryTDunneF. Establishing trimester- and ethnic group-related reference ranges for fructosamine and HbA1c in non-diabetic pregnant women. Ann Clin Biochem.1999;36 (Pt 2): 235–7.
58.
HerranzLSaez-De-IbarraLGrandeCPallardoLF. Non-glycemic-dependent reduction of late pregnancy A1c levels in women with type 1 diabetes. Diabetes Care.2007;30 (6): 1579–80.
59.
O'KaneMJLynchPLMolesKWMageeSE. Determination of a diabetes control and complications trial-aligned HbA(1c) reference range in pregnancy. Clin Chim Acta.2001;311 (2): 157–9.
60.
UlfSRagnarHArneWPJohnnyL. Do high blood glucose peaks contribute to higher HbA1c? Results from repeated continuous glucose measurements in children. World J Pediatr.2008;4 (3): 215–21.
61.
DerrRGarrettEStacyGASaudekCD. Is HbA(1c) affected by glycemic instability?Diabetes Care.2003;26 (10): 2728–33.
62.
BorgRKuenenJCCarstensenBZhengHNathanDMHeineRJNerupJBorch-JohnsenKWitteDR; ADAG Study Group. HbA1(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: The A1C-Derived Average Glucose (ADAG) study. Diabetologia.2011;54 (1): 69–72.
63.
BrownleeMHirschIB. Glycemic variability: A hemoglobin A1c-independent risk factor for diabetic complications. JAMA.2006;295 (14): 1707–8.
64.
SaudekCDDerrRLKalyaniRR. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA.2006;295 (14): 1688–97.
65.
MonnierLColetteC. Glycemic variability: Should we and can we prevent it?Diabetes Care.2008;31Suppl 2: S150–4.
66.
KuenenJCBorgRKuikDJZhengHSchoenfeldDDiamantMNathanDMHeineRJ; ADAG Study Group. Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients?Diabetes Care.2011;34 (8): 1843–7.
67.
StrattonIMAdlerAINeilHAMatthewsDRManleySECullCAHaddenDTurnerRCHolmanRR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ.2000;321 (7258): 405–12.
68.
Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes.1995;44 (8): 968–83.
69.
KleinR. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care.1995;18 (2): 258–68.
70.
WentholtIMKulikWMichelsRPHoekstraJBDeVriesJH. Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia.2008;51 (1): 183–90.
71.
RohlfingCWiedmeyerHMLittleRGrotzVLTennillAEnglandJMadsenRGoldsteinD. Biological variation of glycohemoglobin. Clin Chem.2002;48 (7): 1116–8.
72.
FraserCG. Biological variation: From principles to practice. Washington DC: American Association of Clinical Chemistry Press; 2001.
73.
DiekmanMJSaldenHJDeVriesJH. A patient with hyperglycaemia and normal HbA Ic due to impaired glycation. Neth J Med.2007;65 (10): 395–7.
74.
PhillipovGPhillipsPJ. Components of total measurement error for hemoglobin A(1c) determination. Clin Chem.2001;47 (10): 1851–3.
75.
McCarterRJHempeJMChalewSA. Mean blood glucose and biological variation have greater influence on HbA1c levels than glucose instability: An analysis of data from the Diabetes Control and Complications Trial. Diabetes Care.2006;29 (2): 352–5.
76.
McCarterRJHempeJMGomezRChalewSA. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care.2004;27 (6): 1259–64.
77.
HempeJMGomezRMcCarterRJJrChalewSA. High and low hemoglobin glycation phenotypes in type 1 diabetes: A challenge for interpretation of glycemic control. J Diabetes Complications.2002;16 (5): 313–20.
78.
YudkinJSForrestRDJacksonCARyleAJDavieSGouldBJ. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia.1990;33 (4): 208–15.
79.
KalishGMBarrett-ConnorELaughlinGAGulanskiBI; Postmenopausal Estrogen/Progestin Intervention Trial. Association of endogenous sex hormones and insulin resistance among postmenopausal women: Results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab.2003;88 (4): 1646–52.
80.
AranetaMRBarrett-ConnorE. Ethnic differences in visceral adipose tissue and type 2 diabetes: Filipino, African-American, and white women. Obes Res.2005;13 (8): 1458–65.
81.
SniederHSawtellPARossLWalkerJSpectorTDLeslieRD. HbA(1c) levels are genetically determined even in type 1 diabetes: Evidence from healthy and diabetic twins. Diabetes.2001;50 (12): 2858–63.
82.
CohenRMSniederHLindsellCJBeyanHHawaMIBlinkoSEdwardsRSpectorTDLeslieRD. Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in nondiabetic twins. Diabetes Care.2006;29 (8): 1739–43.
83.
Gallegos-MaciasARMaciasSRKaufmanESkipperBKalishmanN. Relationship between glycemic control, ethnicity and socio-economic status in Hispanic and white non-Hispanic youths with type 1 diabetes mellitus. Pediatr Diabetes.2003;4 (1): 19–23.
84.
EldeirawiKLiptonRB. Predictors of hemoglobin A1c in a national sample of nondiabetic children: The Third National Health and Nutrition Examination Survey, 1988–1994. Am J Epidemiol.2003;157 (7): 624–32.
85.
ManeyMTsengCLSaffordMMMillerDRPogachLM. Impact of self-reported patient characteristics upon assessment of glycemic control in the Veterans Health Administration. Diabetes Care.2007;30 (2): 245–51.
86.
HermanWH. Do race and ethnicity impact hemoglobin A1c independent of glycemia?J Diabetes Sci Technol.2009;3 (4): 656–60.
87.
HermanWHMaYUwaifoGHaffnerSKahnSEHortonESLachinJMMontezMGBrennemanTBarrett-ConnorE; Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care.2007;30 (10): 2453–7.
88.
HermanWHDunganKMWolffenbuttelBHBuseJBFahrbachJLJiangHMartinS. Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. J Clin Endocrinol Metab.2009;94 (5): 1689–94.
89.
ZiemerDCKolmPWeintraubWSVaccarinoVRheeMKTwomblyJGNarayanKMKochDDPhillipsLS. Glucose-independent, black-white differences in hemoglobin A1c levels: A cross-sectional analysis of 2 studies. Ann Intern Med.2010;152 (12): 770–7.
90.
SelvinESteffesMWBallantyneCMHoogeveenRCCoreshJBrancatiFL. Racial differences in glycemic markers: A cross-sectional analysis of community-based data. Ann Intern Med.2011;154 (5): 303–9.
91.
MeigsJBPanhuysenCIMyersRHWilsonPWCupplesLA. A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study. Diabetes.2002;51 (3): 833–40.
92.
Simonis-BikAMEekhoffEMDiamantMBoomsmaDIHeineRJDekkerJMWillemsenGvan LeeuwenMde GeusEJ. The heritability of HbA1c and fasting blood glucose in different measurement settings. Twin Res Hum Genet.2008;11 (6): 597–602.
93.
DubreySWReaveleyDRSeedMLaneDAIrelandHO'DonnellMO'ConnorBNobleMILeslieRD. Risk factors for cardiovascular disease in IDDM. A study of identical twins. Diabetes.1994;43 (6): 831–5.
94.
Borch-JohnsenKNørgaardKHommelEMathiesenERJensenJSDeckertTParvingHH. Is diabetic nephropathy an inherited complication?Kidney Int.1992;41 (4): 719–22.
95.
HietalaKForsblomCSummanenPGroopPH; FinnDiane Study Group. Heritability of proliferative diabetic retinopathy. Diabetes.2008;57 (8): 2176–80.
96.
AvignonARadauceanuAMonnierL. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care.1997;20 (12): 1822–6.
97.
BonoraECalcaterraFLombardiSBonfanteNFormentiniGBonadonnaRCMuggeoM. Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: Implications for treatment and monitoring of metabolic control. Diabetes Care.2001;24 (12): 2023–9.
98.
El-KebbiIMZiemerDCCookCBGallinaDLBarnesCSPhillipsLS. Utility of casual postprandial glucose levels in type 2 diabetes management. Diabetes Care.2004;27 (2): 335–9.
99.
RohlfingCLWiedmeyerHMLittleRREnglandJDTennillAGoldsteinDE. Defining the relationship between plasma glucose and HbA(1c): Analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care.2002;25 (2): 275–8.
100.
PrendergastCSmythOMurrayFCunninghamSKMcKennaTJ. The relationship of blood glucose and haemoglobin A1 levels in diabetic subjects. Ir J Med Sci.1994;163 (5): 233–5.
101.
BastyrEJ3rdStuartCABrodowsRGSchwartzSGrafCJZagarARobertsonKE; IOEZ Study Group. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. Diabetes Care.2000;23 (9): 1236–41.
102.
LevetanCSJengLMThorntonKRWantLRatnerRE. When do glucose values best correlate with hemoglobin A1c?Diabetes.2001;50 (2 Suppl): A124.
103.
KovatchevBPCoxDJStraumeMFarhyLS. Association of self-monitoring blood glucose profiles with glycosylated hemoglobin in patients with insulin-dependent diabetes. Methods Enzymol.2000;321: 410–7.
104.
PetersonCMJonesRLDupuisALevineBSBernsteinRO'SheaM. Feasibility of improved blood glucose control in patients with insulin-dependent diabetes mellitus. Diabetes Care.1979;2 (4): 329–35.
105.
DitzelJKjaergaardJJ. Haemoglobin AIc concentrations after initial insulin treatment for newly discovered diabetes. Br Med J.1978;1 (6115): 741–2.
106.
American Diabetes Association. Standards of medical care in diabetes–2011. Diabetes Care.2011;34Suppl 1: S11–61.
107.
MakrisKSpanouLRambaouni-AntoneliAKoniariKDrakopoulosIRizosDHaliassosA. Relationship between mean blood glucose and glycated haemoglobin in type 2 diabetic patients. Diabet Med.2008;25 (2): 174–8.
108.
NathanDMTurgeonHReganS. Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia.2007;50 (11): 2239–44.
109.
MurataGHHoffmanRMDuckworthWCWendelCSShahJH; Diabetes Outcomes in Veterans Study. Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: The diabetes outcomes in veterans study (DOVES). Am J Med Sci.2004;327 (6): 319–23.
110.
NathanDMKuenenJBorgRZhengHSchoenfeldDHeineRJ; A1c-Derived Average Glucose Study Group. Translating the A1c assay into estimated average glucose values. Diabetes Care.2008;31 (8): 1473–8.
111.
Diabetes Research in Children Network (DirecNet) Study Group, Wilson DM, Kollman. Relationship of A1C to glucose concentrations in children with type 1 diabetes: Assessments by high-frequency glucose determinations by sensors. Diabetes Care.2008;31 (3): 381–5.
112.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Wilson DM, Xing D, Beck RW, Block J, Bode B, Fox LA, Hirsch I, Kollman C, Laffel L, Ruedy KJ, Steffes M, Tamborlane WV. Hemoglobin A1c and mean glucose in patients with type 1 diabetes: Analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Care.2011;34 (3): 540–4.
113.
BorgRKuenenJCCarstensenBZhengHNathanDMHeineRJNerupJBorch-JohnsenKWitteDR; ADAG Study Group. Associations between features of glucose exposure and A1C: The A1C-Derived Average Glucose (ADAG) study. Diabetes.2010;59 (7): 1585–90.
114.
BorgRKuenenJCCarstensenBZhengHNathanDMHeineRJNerupJBorch-JohnsenKWitteDR; ADAG Study Group. Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: The A1c-Derived Average Glucose (ADAG) study. Diabetologia.2010;53 (8): 1608–11.
115.
WeykampCJohnWGMoscaA. A review of the challenge in measuring Hemoglobin A1c. J Diabetes Sci Technol.2009;3 (3): 439–45.
116.
WeykampCJohnWGMoscaAHoshinoTLittleRJeppssonJOGoodallIMiedemaKMyersGReinauerHSacksDBSlingerlandRSiebelderC. The IFCC reference measurement system for HbA1c: A 6-year progress report. Clin Chem.2008;54 (2): 240–8.
117.
Lenters-WestraESlingerlandRJ. Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem.2010;56 (1): 44–52.
118.
ChangAFrankJKnaebelJFullamJPardoSSimmonsDA. Evaluation of an over-the-counter glycated hemoglobin (A1c) test kit. J Diabetes Sci Technol.2010;4 (6): 1495–503.
119.
DunganKChapmanJBraithwaiteSSBuseJ. Glucose measurement: Confounding issues in setting targets for inpatient management. Diabetes Care.2007;30 (2): 403–9.
120.
LyonMEDuBoisJAFickGHLyonAW. Estimates of total analytical error in consumer and hospital glucose meters contributed by hematocrit, maltose, and ascorbate. J Diabetes Sci Technol.2010;4 (6): 1479–94.
